How many institutions held KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share in Q2 2026?

20 institutional investors reported KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share for Q2 2026. Use the holders table for investor-level position and value details.

Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)

Q: What does CUSIP 50127T109 represent in this 13F holders report?

CUSIP 50127T109 is the security identifier for KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 50127T109

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 1,382,028
Total 13F value: $15,005,696
Share change: +454,611
SEC-reported price per share: $10.97
Number of holders: 20
Value change: +$4,984,633
Number of buys: 13
Number of sells: 3
Shares outstanding: 88,321,513

Security key

50127T109

Report period

Q2 2026

Institutions

Top holders

KURA full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Kura Oncology, Inc. SEC filings Kura Oncology, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 50127T109

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BIOTECHNOLOGY VALUE FUND L P

Disclosed value leader

BlackRock, Inc.

Comparable rows

15/15

Latest evidence

31 Mar 2026

13D/G 13F Lead comparable stake: 10% 13D/G row: BIOTECHNOLOGY VALUE FUND L P Showing 1-6 of 15 holder rows.

Quick read

BIOTECHNOLOGY VALUE FUND L P leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BIOTECHNOLOGY VALUE FUND L P's linked filing trail.

Comparable ownership Top 5

BIOTECHNOLOGY VALUE FUND L P 10%

SUVRETTA CAPITAL MANAGEMENT, LLC 9.4%

BlackRock, Inc. 7.8%

STATE STREET CORP 5.7%

VANGUARD CAPITAL MANAGEMENT LLC 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BIOTECHNOLOGY VALUE FUND L P	13D/G BVF PARTNERS L P/IL 13D/G	10%	$76,791,609 8,677,018 shares	+$24,465,506	30 Sep 2025
SUVRETTA CAPITAL MANAGEMENT, LLC	13F 13D/G Company 13F 13D/G	9.4% from 13D/G	$69,718,181 8,575,422 shares	—	31 Mar 2026
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	7.8% from 13D/G	$78,353,125 9,637,531 shares	—	31 Mar 2026
STATE STREET CORP	13D/G 13F STATE STREET CORPORATION · Company 13D/G 13F	5.7%	$45,218,095 4,931,090 shares	$0	31 Dec 2025
VANGUARD CAPITAL MANAGEMENT LLC	13D/G 13F Vanguard Capital Management · Company 13D/G 13F	5%	$36,006,242 4,428,812 shares	$0	31 Mar 2026
RA CAPITAL MANAGEMENT, L.P.	13D/G 13D/G	4.9%	$26,070,011 4,004,610 shares	$0	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,382,028

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

218

Q2 2026 holders

Holder diff

-198

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend